Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class

Cancer Research

Volumn 60, Issue 18, 2000, Pages 5143-5150

  Kilic, T ^a   Alberta, J A ^a   Zdunek, P R ^a   Acar, M ^a   Iannarelli, P ^a   O'Reilly, T ^a   Buchdunger, E ^a   Black, P M ^a   Stiles, C D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; STI 571; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME INHIBITION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

3T3 CELLS; ANIMAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BRAIN NEOPLASMS; CELL DIVISION; CELL TRANSFORMATION, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLIOBLASTOMA; GROWTH INHIBITORS; HELA CELLS; HUMAN; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-TYROSINE KINASE; PYRIMIDINES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0034665138     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cancer epidemiology
2. Neoplasms of the central nervous system
3. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas
4. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen
5. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
6. Clinical efficacy and safety of an AbI specific tyrosine kinase inhibitor as targeted therapy for chronic myelogenous leukemia
7. Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines
8. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
9. In vivo expression of PDGF and PDGF receptors in human astrocytomas
10. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance
11. Is PDGF really important? Testing the hypothesis
12. Structure of platelet-derived growth factor: Implications for functional properties
13. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus
14. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells
15. Receptors for platelet derived growth factor in human glioma cell lines and influence of suramin on cell proliferation
16. Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant
17. Dominant negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells
18. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-β receptor
19. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line
20. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
21. Detection of activated PDGF receptors in human meningioma
22. A tiger behind many doors: Multiple genetic pathways to malignant glioma
23. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor a receptor expression in human malignant gliomas
24. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
25. p73 Is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage
26. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
27. Interaction of c-Abl and p73α and their collaboration to induce apoptosis